- Shoppers Drug Mart is now the exclusive direct-to-patient online provider of FlowrRx products
- The agreement between Flowr Corporation and Shoppers Drug Mart is expected to solidify Flowr’s leading position in the Canadian medicinal cannabis market
- Flowr is already a leader in terms of high yields and low production costs – two factors that are proving to be determining for the success of cannabis companies
FlowrRX products by The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) are now available for purchase through the Shoppers Drug Mart online medical cannabis platform, as the company announced on March 18, 2019 (http://ibn.fm/rV9dS).
The two companies confirmed a sales agreement at the beginning of 2019. Through the partnership, The Flowr Corporation and Shoppers Drug Mart are simplifying the delivery of medical cannabis products in Canada.
“Flowr’s premium medical cannabis is grown in what we believe is the industry’s most advanced GMP designed cultivation facility. This relationship is testament to our commitment to ultra-high-quality cannabis cultivation and further solidifies Flowr’s role in Canada’s medical cannabis landscape,” co-CEO Vinay Tolia said in a news release.
To order FlowerRX products, patients are required to submit a completed medical document from a health care practitioner to Shoppers Drug Mart. Company advisers will next contact the health care practitioner to verify the document and ensure the immediate completion of the order.
Previously, FlowrRX products were available via the Flowr online store. As per a 2019 agreement, Shoppers Drug Mart is now the exclusive direct-to-patient distributor of FlowrRX products.
Featuring premium quality medicinal cannabis, the FlowrRX range of offerings is the result of Flowr Corporation’s research and development team focusing on innovative cultivars and the creation of unique products. High quality customer service is another key to the delivery of reliable solutions under the FlowrRX brand.
The FlowrRX premium product delivery program incorporates the use of multiple strains ranging from high THC to more balanced options and featuring the company’s BC Delahaze. Delahaze is an award-winning cultivar known for the strong invigorating effect. The cultivar is grown in the Flowr Corporation’s indoor facility to put emphasis on both potency and flavor through consistent control over the cultivation process.
Flowr Corporation is a Health Canada Licensed Producer of cannabis under the Access to Cannabis for Medical Purposes Regulations. The company is emerging as a Canadian leader in the field as a result of its highly advanced, purpose-built cultivation facilities.
Through its innovative cultivation practices, Flowr consistently generates the high crop yields needed for the delivery of premium and ultra-premium cannabis products.
Control over cultivation and innovative practices result in a cost-efficient cultivation process. As the company notes, high yields per square foot are key to ensuring low operating costs and profitability.
For more information, visit the company’s website at www.Flowr.ca
NOTE TO INVESTORS: The latest news and updates relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF